Eton Pharmaceuticals, Inc. Property, Plant and Equipment, Gross
Eton Pharmaceuticals, Inc. (ETON) had Property, Plant and Equipment, Gross of $466.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Gross $466.00K.
- 2026-03-31: Property, Plant and Equipment, Gross $880.00K.
- 2025-12-31: Property, Plant and Equipment, Gross $812.00K.
- 2024-12-31: Property, Plant and Equipment, Gross $480.00K.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $466.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $880.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $812.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $480.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $467.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $467.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $467.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $453.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $421.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $421.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $421.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $424.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $412.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $412.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $424.00K 10-Q · filed 2023-05-11 | $481.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $466.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $463.00K 10-Q · filed 2021-11-16 | |
| 2021-06-30 | $461.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $581.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.50M 10-K · filed 2022-03-16 | |
| 2020-09-30 | $1.46M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.46M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.46M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.46M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.43M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.40M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.27M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $835.00K 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |